Navigate this market better. Subscribe for FREE stock alerts and information.

Friday, August 22, 2014

Valeant, Ackman to submit Allergan special meeting request-CNBC, (NYSE: AGN), (NYSE: VRX), (TSE: VRX.TO)

Valeant Pharmaceuticals International Inc and Pershing Square Capital Management will submit a request on Friday to Allergan Inc for a special shareholders meeting, sources told CNBC television. Allergan's corporate bylaws require Valeant and Pershing Square to have more than 25 percent of shareholders' votes in favor of holding the meeting. They have support from more than 30 percent, CNBC reported, citing the sources.

Allergan, Inc. is a multi-specialty health care Company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. Shares of AGN fell by 1.0% or $-1.64/share to $162.74. In the past year, the shares have traded as low as $86.95 and as high as $174.49. On average, 2819880 shares of AGN exchange hands on a given day and today's volume is recorded at 280176.

Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX traded higher by 0.33% or $0.38/share to $114.19. In the past year, the shares have traded as low as $95.28 and as high as $153.10. On average, 3257230 shares of VRX exchange hands on a given day and today's volume is recorded at 300002.

Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX traded higher by 0.36% or $0.45/share to $124.99. In the past year, the shares have traded as low as $99.90 and as high as $170.45. On average, 355388 shares of VRX.TO exchange hands on a given day and today's volume is recorded at 28892.



Source